Newsroom

HOUSTON--(BUSINESS WIRE)--Phillips 66 announced that the board of directors has approved a $10 billion increase to the share repurchase authorization....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Capital Strength UCITS ETF 30.07.2026 FTCS. IE00BL0L0D23  275,002.00 USD   9,520,913.14   34.621  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 30.07.2026 FVD. IE00BKVKW020  250,002.00 USD   7,705,586.28   30.822  ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it will publish financial results for the second quarter 2026 and provide a business update on Thursday, August 6, 2026. About Precision BioSciences, Inc. Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improvin...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 30.07.2026 FCSG IE00BKPSPT20 750,002.00 USD 34,688,620.95 46.251  ...

AUSTIN, Texas--(BUSINESS WIRE)--Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas”), a leading energy solutions provider, today announced an expansion of its autonomous truck operations in the Permian Basin, advancing its commitment to unlocking energy by digitally transforming oilfield logistics.Working with Kodiak AI, Inc. (“Kodiak”) (Nasdaq: KDK), a leading provider of Physical AI-powered autonomous driving technology, Atlas is expanding its driverless proppant delivery program to a second sim...

BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to the reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration. The applications wer...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AutoNation, Inc. (NYSE: AN) today reported second quarter 2026 revenue of $6.9 billion, a decrease of 1% compared to the same period a year ago. Second quarter 2026 EPS was $5.39, compared to $2.26 a year ago, and second quarter 2026 Adjusted EPS was $5.56, compared to $5.46 a year ago. Reconciliations of non-GAAP financial measures are included in the attached financial tables. “We are pleased to report another quarter of strong performance, including re...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 30.07.2026 FTFX IE00BD5HBQ97   63,402.00 USD   1,759,116.40   27.745  ...

EWING, N.J.--(BUSINESS WIRE)--Church & Dwight Co., Inc. (NYSE: CHD) today announced that the Company exceeded its second quarter outlook with stronger than expected sales and earnings growth. Net sales increased 1.6% to $1,530.0 million in the second quarter, exceeding the Company’s outlook of a 1% decline and reflecting the benefits of its successful 2025 strategic portfolio actions. Organic sales growth accelerated to 5.8%, well above the Company’s 3% outlook, with growth across all three...